EUVIMEDEUVIMED entdecken
Crossref

Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J Davies iD, Vanita R Aroda iD, Mandeep Bajaj iD, Nuha A ElSayed iD, Francesco Giorgino iD, Jennifer Green iD, Rita R Kalyani iD, Nisa M Maruthur iD, Chantal Mathieu iD, Sylvia E Rosas iD, Peter Rossing iD, Tommy Slater iD und 4 weitere

Diabetes Care · 02.10.2026

DOI: 10.2337/dci26-0141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 02.10.2026. Verfasst von Melanie J Davies und 15 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Centre, College of Life Sciences, Leicester General Hospital, University of Leicester, Leicester, U.K. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Gefördert von: European Association for the Study of Diabetes, American Diabetes Association.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the consensus statement on the management of type 2 diabetes in nonpregnant adults, published since 2006 and last updated in 2022. The target audience is the multidisciplinary health care team providing diabetes care in the U.S. and Europe. A systematic examination of publications since 2022 informed new recommendations. This update has broadened the focus from the management of hyperglycemia to the holistic management of type 2 diabetes and its risk of associated multiple long-term conditions. Fundamental aspects of diabetes care include promoting healthy lifestyle behaviors (healthy eating, 24-h physical behaviors including sleep, and avoiding tobacco and substance use), alongside the provision of psychological support and weight management interventions. For the management of people living with type 2 diabetes, earlier use, potentially from diagnosis, of sodium–glucose cotransporter 2 (SGLT2) inhibitors and/or glucagon-like peptide 1 (GLP-1)-based therapies to offer organ protection and improve long-term outcomes in type 2 diabetes is advocated. Furthermore, earlier combination use of SGLT2 inhibitors and GLP-1–based therapies should be considered in people with concomitant cardiovascular disease, chronic kidney disease, and heart failure. Finally, the ability to transform outcomes for people living with type 2 diabetes is within our grasp through the consistent, equitable, and systematic implementation of strategies and therapies that are already available.

Autor:innen und Institutionen

  • Diabetes Research Centre, College of Life Sciences, Leicester General Hospital, University of Leicester, Leicester, U.K.
  • NIHR Leicester Biomedical Research Centre, University Hospitals of Leicester NHS Trust, Leicester, U.K.
  • Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX.
  • Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Diabetes Education for All Foundation, New York, NY.

ORCID-Profile: Melanie J Davies, Vanita R Aroda, Mandeep Bajaj, Nuha A ElSayed, Francesco Giorgino, Jennifer Green, Rita R Kalyani, Nisa M Maruthur, Chantal Mathieu, Sylvia E Rosas, Peter Rossing, Tommy Slater, Tsvetalina Tankova, Pinar Topsever, Apostolos Tsapas, John B Buse

Förderung

  • European Association for the Study of Diabetes
  • American Diabetes Association

Zitieren

APA

Davies, M. J., Aroda, V. R., Bajaj, M., ElSayed, N. A., Giorgino, F., Green, J., Kalyani, R. R., Maruthur, N. M., Mathieu, C., Rosas, S. E., Rossing, P., Slater, T., Tankova, T., Topsever, P., Tsapas, A., & Buse, J. B. (2026). Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. https://doi.org/10.2337/dci26-0141

Vancouver

Davies MJ, Aroda VR, Bajaj M, ElSayed NA, Giorgino F, Green J, et al. Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2026. doi:10.2337/dci26-0141

BibTeX
@article{Davies2026,
  author = {Davies, Melanie J and Aroda, Vanita R and Bajaj, Mandeep and ElSayed, Nuha A and Giorgino, Francesco and Green, Jennifer and Kalyani, Rita R and Maruthur, Nisa M and Mathieu, Chantal and Rosas, Sylvia E and Rossing, Peter and Slater, Tommy and Tankova, Tsvetalina and Topsever, Pinar and Tsapas, Apostolos and Buse, John B},
  title = {Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)},
  journal = {Diabetes Care},
  year = {2026},
  doi = {10.2337/dci26-0141}
}
Kostenlos starten →